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ABSTRACT: Minimally invasive robot-assisted surgery is a technological development that has changed the field of 
medicine in the past decade. The introduction of the da Vinci® by Intuitive Surgical Inc. has opened up many interesting 
options in several different fields. Specifically, the field of urology has seen increased utilization of the robotic technique 
due to the precision allowed by the technology. Although many perioperative and postoperative benefits have been 
documented within the literature pertaining to robotic surgery, some surgeons contend that the extra cost associated 
with the procedures is not practical. To this point the extra cost has not been prohibitive, as the number of robot-
assisted procedures has continued to increase in the years since FDA approval. In this study, we employed an analysis 
of three of the more commonly performed da Vinci® robotic urology procedures (prostatectomy, pyeloplasty, and 
nephrectomy) to assess the practicality of the robotic techniques as compared to the more established methods of 
laparoscopic or open urologic surgery. The study results displayed that robotic integration is more practical for all three 
of the surgeries reviewed. Factors that influenced the results were the tendencies of robot-assisted procedures to have 
similar outcomes to laparoscopic or open procedures while allowing for less estimated blood loss and a shorter length 
of hospital stay. This paper discusses the results from the practicality evaluation as well as how these findings should be 
interpreted.
KEYWORDS: robotic surgery; da Vinci® robot; robotic urology; prostatectomy; pyeloplasty; nephrectomy; cystectomy
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INTRODUCTION
Modern urologic surgery traces back to 1947 when 
Millin described the first retropubic approach to radical 
prostatectomy.1 Although surgeons continued to improve 
on their outcomes, it was not until 1991 that Clayman 
first described and utilized techniques needed to perform 
the first laparoscopic nephrectomy.2 With newfound 
hope for patients, an opportunity arose for further 
advancement of minimally invasive surgery with the 
advent of surgical robots in the late 1990s. The traditional 
challenges of urologic surgery appear to offer an apt 
avenue for displaying the benefits of minimally invasive 
robot-assisted surgery. Since the introduction of robot-
assisted surgery, surgeons have wondered whether there 
was a place for such revolutionary methods. For some 
time, robotic surgery was seen as a gimmick and an 
unrealistic option for the masses. However, the 
introduction of the da Vinci® surgical system has helped 
to gain acceptance for robotic surgery within the last ten 
years, allowing for a variety of procedures to be performed 
using minimally invasive techniques. The current 
viewpoint has shifted, as leaders in the medical field have 
incorporated robotic surgery into their repertoire, and 
have found it to be a viable and sometimes more 
successful option than traditional laparoscopy. 
Using robots for medical or surgical purposes is a 
relatively recent development, with the first known 
application of a surgical robotic device, Programmable 
Universal Manipulation Arm (PUMA), used in 1985 to 
orientate a needle for a radiologically guided brain 
biopsy.3 As of 2010, more than 800 U.S. hospitals and 
2500 surgeons have acquired and incorporated at least 
one robot into their surgical techniques.4 The field of 
surgical robotics has seen numerous technological 
developments in its brief history in medicine, including 
the development of several different revolutionary 
machines, most notably the da Vinci® by Intuitive 
Surgical Inc. The da Vinci® is a high definition and 
three-dimensional tremor-eliminating system with the 
ability to decrease the learning curve of a new surgeon.5 
It is currently in widespread use in several different 
subspecialties, such as urology, cardiothoracic surgery, 
and gynecology. There are a number of docu- mented  
peri-operative  advantages generally observed with 
surgeries performed with the da Vinci®, including 
decreased blood loss, decreased pain, and shorter 
hospitalizations. Frequently observed  disadvantages of 
the da Vinci® system include the costs associated with 
the initial purchase ($1.6 million) and the annual 
maintenance, which totals over $100,000 per year.6 
Another major concern is the loss of the surgeon’s tactile 
sensation, an issue to which surgeons with more 
experience on the robotic platform have been able to 
adapt.7-9 Overall, the da Vinci’s® versatility has allowed 
for further exploration into the field of Minimally 
Invasive Surgery and could expand surgical treatment 
methods beyond what was once conceivable.10
THE DA VINCI® SURGICAL SYSTEM
The da Vinci® is currently the most commonly used 
robotic surgical system used in urology. Over 1,450 
academic and community hospital sites have installed 
the system since its approval, and growth has come in 
excess of 25% annually.11 The system’s uses extend to 
various procedures within different medical fields, 
including urology, gynecology, otolaryngology, and 
cardiothoracics. The S-model system is separated into 
three general components: the surgeon’s console, the 
patient side cart and the 3-D Vision System. The 
surgeon’s console, located several feet from the patient, 
controls four electro-mechanical arms as well as a video 
endoscope. Inside the surgeon’s console, a magnified 
three-dimensional image is displayed on the visual 
display system. The surgeon uses controls that relay 
motion to the robotic arms, which manage the specific 
instruments and video endoscope operating at the patient 
side cart. Intuitive Surgical has developed Endowrist 
technology, which allows the surgeon to use seven 
degrees of freedom, while extending the traditional angle 
of rotation allowed by the human arm and wrist. Many 
supporters of the da Vinci® believe that this added 
dexterity provided by Endowrist® technology is the 
device’s greatest advantage, which allows easier and more 
precise suturing.12 The da Vinci® is considered to be a 
single quadrant system allowing for work to be performed 
on only one quadrant of the body at a time. However, the 
patient side cart is mobile and able to move freely when 
the system is not set to operate, allowing for numerous 
possible angles and locations for surgical entry. The da 
Vinci® has been redesigned several times since its 
creation, and will most likely be developed further as 
surgeons continue to incorporate the technology.
PURPOSE
Considering the dynamic climate of the United States 
healthcare market, return on investment is increasingly 
important for hospitals and healthcare professionals. 
Successful outcomes have become progressively more 
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difficult to define, and the issue of medical procedures 
and their inherent practicality seems to have been 
clouded somewhere along the line. The recent 
introduction of robotic surgery, especially within the 
field of urology, has generated much debate regarding 
the cost versus benefit of these newfound techniques. 
Considering the costs associated with the da Vinci®, we 
found it essential to add to the discourse a preliminary 
practicality analysis for three separate robotic urology 
procedures. The purpose of this paper is to assess the 
practicality of performing three distinct urologic 
procedures--radical prostatectomy, pyeloplasty, and 
partial nephrectomy--using the da Vinci® surgical 
system. Our goals are to determine if the robotic 
approach is a more practical method of surgery for each 
procedure when compared to the current “gold standard” 
method of traditional laparoscopy and to give 
recommendations to the field based on the results.
STUDY DESIGN
We employed a retrospective analysis of three of the 
more commonly performed da Vinci® robotic urology 
procedures to assess the practicality of these newly 
established robotic techniques as compared to the more 
established methods of laparoscopic urologic surgery.We 
will assess each of the three surgical procedures--radical 
prostatectomy, pyeloplasty, and partial nephrectomy--
with an experimental assessment tool to determine if the 
da Vinci® robotic technique is a practical approach to 
urologic surgery when compared to the standard methods 
of treatment. We will then conclude with a statement on 
the practical use of each procedure as they pertain to our 
assessment.
LITERATURE SEARCH STRATEGY
We screened appropriate literature from provided 
abstracts. The search strategy for relevant literature 
included the following: Ovid Medline (1950 to present), 
CINAHL (1982 to present), PsycInfo (1806 to present), 
All EBM Reviews, Ovid Healthstar (1966 to present), 
ERIC, PubMed, and Google Scholar (2011-2012). 
Further, we conducted ancestry and gray literature 
searches to ensure full capture of relevant research. The 
gray literature searches were confined to conferences and 
dissertation research concerning the daVinci® procedure. 
All databases except for PubMed, Google Scholar, and 
ERIC use OVID Gateway. PubMed and Google Scholar 
use their own searching catalogs while ERIC employs 
EBSCOhost.  Keyword search phrases included: robotic 
surgery, da Vinci® robot, robotic urology, prostatectomy, 
pyeloplasty, nephrectomy, video assisted laparoscopic/
robotic/robot-assisted. This process yielded a total of 717 
search results displaying relevant information (Table 1). 
Of these 717 results, over half were immediately screened 
out due to failure to meet some or all of our primary 
criteria, which included the following characteristics: 
study design, operative time, length of hospital stay, cost, 
and estimated blood loss. After initial screening, the 
results were reviewed further. Observational and 
comparative studies were utilized when compiling the 
data; however, only sufficiently large samples were 
considered. Finally, the information was further narrowed 
down to large meta-analyses and comprehensive 
literature reviews. Comparative meta-analyses were 
included in the study whenever possible and therefore 
compose the bulk of the results. Case series reporting 
exclusively on robotic methods or laparoscopic/open 
methods were included if no other substantial 
comparative literature existed within the search results. 
In total, nine articles containing analyses from 91 
separate studies were used to construct our results.
MEASUREMENTS/INSTRUMENTATION
An original research based, mathematical tool was used 
by the team to assess practicality. This exploratory 
assessment tool consisted of the following criteria: 
quantitative patient costs, estimated peri-operative blood 
loss (EBL), operative duration, and length of hospital 
stay. Qualitative data, such as the opinions of experienced 
surgeons within the field, were included in the 
manuscript, but did not contribute to the practicality 
scores within the tables. For each of the three procedures, 
both the da Vinci® robotic technique as well as the gold 
standard technique were scored in the four 
aforementioned categories. Each procedure was selected 
because of the diverse challenges they present, which 
allowed for a more comprehensive analysis. Patient costs, 
estimated peri-operative blood loss, operative duration, 
and length of hospital stay were selected to determine 
the practicality of each method due to their regular 
occurrence in the literature related to urologic surgery 
outcomes. Additionally, these criteria are common to the 
three procedures that were evaluated, whereas other 
outcome variables within the literature may only be 
relevant to procedures involving cancer surgery or 
reconstruction. 
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Each of the four criteria has previously been cited 
throughout the literature involving surgery outcomes 
and are thus of importance to this study. Poorly controlled 
surgical blood loss can contribute to increases in 
postoperative mortality, major morbidity, and length of 
hospital stay.13 Additionally, excess surgery duration is 
frequently cited as a major risk factor for postoperative 
complications.14 While length of hospital stay may not 
be independent from perioperative blood loss, operative 
duration, and cost, it is of great importance to overall 
surgical success because reduced hospital stay has been 
shown to result in significant cost savings without 
increasing morbidity.15 Within this pilot scoring tool, 
each of the four categories within the data set are scored 
with a value between 1-5 (Table 2). A lower assigned 
number value correlates with a more practical value. For 
example, a score of 1 represents the most desirable value 
in each criterion category, whereas a score of 5 represents 
a larger and less optimal value. Within the category of 
estimated blood loss (EBL), a 1 corresponds to less than 
150 mL and a 5 corresponds to more than 300 mL of 
blood. Operative duration is analyzed in the same way, 
with a score of 1 representing a brief procedure shorter 
than 120 minutes and a score of 5 representing a 
procedure over 210 minutes. Additionally, length of 
hospital stay was analyzed, using less than one day as the 
ideal value of 1 and a stay longer than 2.6 days as the 
least desirable outcome. Cost was the final quantitative 
criterion analyzed. A cost of $5,500 or less corresponds 
to a score of 1, whereas a score of 5 is assessed to a 
procedure costing over $10,000. (Table 2 describes the 
intervals in which the data have been divided.) A final 
mean practicality score will be calculated in Table 3 by 
taking an average of each of the four category scores. If 
the calculated mean practicality score is less than the 
more traditional laparoscopic method, it will be 
considered more practical. It is important to note that 
the mean scores are meant to be utilized as a within 
comparison between two identical procedure types 
performed using two different techniques. The 5-point 
score standardization scale located in Tables 2 and 4 has 
strictly been utilized for greater ease of understanding. 
Therefore, the mean practicality score of one type of 
procedure bears no relevance to the mean practicality 
score of another. This study does not compare practicality 
between two different types of procedures. All specific 
numerical statistics pertaining to observed perioperative 
and postoperative outcomes can be located in Table 3, 
while mean practicality results can be located in Table 4.
RESULTS
Robot-Assisted Radical Prostatectomy (RARP)
Robot-assisted radical prostatectomy (RARP) is a 
procedure used to remove the prostate gland and the 
seminal vesicle, most often performed to treat localized 
prostate cancer.16 Robot-assisted prostatectomy is easily 
the most common robotic procedure performed today; it 
has experienced exponential growth in the years 
following its approval by the Food and Drug 
Administration (FDA) in 2000.16 Between 2003 and 
2004 the number of surgeries increased threefold, and 
statistics indicate that robot-assisted prostatectomy is 
gaining popularity throughout the United States.17 
Although robot-assisted prostatectomy is gaining 
popularity, some practitioners remain skeptical, mainly 
due to the limited long-term research currently available. 
However, robotic prostatectomy is widely associated 
with several peri-operative and post-operative benefits, 
including decreased blood loss, decreased post-operative 
pain, and shorter hospitalizations when compared with 
retropubic or traditional laparoscopic prostatectomy.18-22 
While Ficarra’s 2009 meta-analysis shows similar blood 
loss between the two techniques,22 a 2005 study shows 
that RARP displayed far less EBL when compared to 
traditional laparoscopy (206 vs 299 ml).19 It also seems 
that midterm recovery is a benefit of robot-assisted 
prostatectomy. Comparisons with traditional laparoscopic 
radical prostatectomy (LRP) surgeries showed that while 
patients from both methods regained their continence in 
the long-term, those who underwent robotic 
prostatectomy were more likely to do so within the first 
six months (68-96% compared to 43-80%).22 
Additionally, a comprehensive study by Patel et al 
displayed increased trifecta (continence, potency, and 
prostate specific antigen) outcome rates at six weeks, 
three, six, twelve and eighteen months after RARP 
(42.8%, 65.3%, 80.3%, 86% and 91% respectively).23 
Another benefit of the da Vinci® surgical system is that 
it appears to minimize the learning curve for new 
surgeons due to the added dexterity, which is so vital 
within the pelvis.12 
Currently, most of the disadvantages associated with 
robot-assisted prostatectomy seem to be monetary. To 
this point, LRP continues to be more affordable than 
RARP by around $1200, mostly due to the initial 
purchase of the equipment.21, 24, 25 While the initial 
purchase and maintenance costs of a da Vinci® surgical 
system are quite high, they do not seem to be prohibitive 
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given the increase in the amount of robot-assisted 
prostatectomy procedures being performed at many 
locations. An additional factor that must be evaluated is 
total operative time. While robot-assisted prostatectomy 
initially seems to have a longer total operative time in the 
early phase, operative duration decreases with 
experience.26 Several recent studies have found RARP to 
have a shorter average duration.22, 27 Due to the growth 
and popularity of robot-assisted prostatectomy, some 
experienced surgeons at high-volume centers are now 
able to complete the procedure within 90 minutes.22 
Long-term oncologic outcomes are limited, but the 
existing literature seems encouraging. A 2011 study 
evaluating 3625 patients over eight years concluded that 
RARP offers effective long-term biochemical control.28 
Currently, with cost being one of the only barriers, it 
seems that the frequency of RARP will continue to rise 
in the future due to the procedure’s successes.
Robot-Assisted Pyeloplasty
Pyeloplasty has become the standard surgical treatment 
for ureteropelvic junction obstruction (UJO) to allow 
urinary flow from the renal pelvis into the ureter.12 The 
first robot-assisted pyeloplasty was performed on a swine 
model by Sung and co-authors using the Zeus® surgical 
system in 1999. The team concluded that robot-assisted 
laparoscopic pyeloplasty is a feasible and effective 
procedure that may enhance surgical dexterity and 
precision.29 With the increasing use of the da Vinci® 
surgical system, the frequency of robot-assisted 
pyeloplasty has continued to grow. It appears that both 
laparoscopic pyeloplasty and robotic pyeloplasty have 
similar outcomes in terms of their success rates. As of 
2006, Bhayani and co-authors concluded that robot-
assisted pyeloplasty had no distinct advantage when 
compared with traditional laparoscopic pyeloplasty 
performed by an experienced surgeon.30 However, since 
then the robotic method has continued to improve, and 
results point to several common advantages in decreasing 
mean estimated blood loss (50 vs. 158 ml) and mean 
hospital stay (1.54 vs. 1.98 days).31-33 In addition, a 
comprehensive comparison of two large-scale literature 
reviews found that robot-assisted pyeloplasty has shorter 
operating time (194 vs 224 mins) when compared to the 
laparoscopic method.31, 33 The enhanced suturing ability 
often associated with the robotic platform is ideal for the 
efficient reconstruction needed for the procedure. Those 
with advanced robotic laparoscopy skills have completed 
the procedure in as few as 60 minutes.34 Further benefits 
of robot-assisted pyeloplasty include the potential to 
reduce technical challenges of laparoscopic pyeloplasty, 
which is considered a challenging procedure even for 
most skilled laparoscopic surgeons.35 Although 
evaluation of costs shows that robot-assisted pyeloplasty 
can be more costly ($10,635 vs $9,065) than laparoscopic 
or open methods,33 the procedure will likely continue to 
gain in popularity due to these documented advantages.
Robot-Assisted Partial Nephrectomy (RAPN)
Nephrectomy is the surgical removal of all or part of the 
kidney, which is often performed in patients with renal 
cell carcinoma.36 The application of robotics to partial 
nephrectomy is a recent technique in the field, with the 
first robot-assisted partial nephrectomy performed by 
Gettman in 2004.37 Currently robot-assisted partial 
nephrectomy (RAPN) is a viable option for patients who 
desire a minimally invasive option for the performance 
of nephron-sparing surgery.38 Most of the benefits of 
RAPN, such as less EBL and shorter hospital stay, 36, 39 
can be attributed to enhanced suturing dexterity when 
compared to laparoscopic techniques.40 Moreover, 
RAPN is associated with a shorter total operative time 36, 41 
as well as a decreased learning curve.42, 43 Benway suggests 
RAPN is a safe and viable alternative to laparoscopic 
partial nephrectomy, “<that it> may provide maximal 
renal nerve preservation,” 43 which is vital in the 
sympathetic regulation of the nephron and renin-
angiotensin system.44 Much like what is seen in both 
RARP and robot-assisted pyeloplasty, the cost of RAPN 
is greater than that of Laparoscopic methods by roughly 
$1,500 per surgery.39 An additional limitation related to 
the cost of RAPN is the need for a bedside assistant, a 
factor that presents further challenges in robot 
integration. Similar to many robot-assisted procedures, 
the long-term oncologic effects of RAPN have yet to be 
seen. It requires further exploration since the first 
recorded procedure was performed in 2004. As surgeons’ 
experience increases, patients will experience the benefits 
of RAPN, and the use of robotics for partial nephrectomy 
should continue to grow.
RESULTS ANALYSIS
The results indicate that robotic integration is more 
practical for each of the three surgeries reviewed in this 
research project. Factors that influenced the results were 
the propensity of robot-assisted procedures to produce 
similar outcomes to laparoscopic procedures while 
allowing for less blood loss and a shorter length of 
hospital stay. Laparoscopic and open procedures scored 
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better in categories such as cost, while operative duration 
was highly dependent on the individual procedure. 
Additionally, while the cost of surgery is higher in the 
robotic cohort, the decreased hospital stay occasionally 
brings the patient’s expenses within the range of more 
traditional surgical methods. Although not included in 
the numerical practicality analysis, the literature review 
revealed several opinions on the practicality of the robotic 
technique when used on the three urologic procedures 
assessed in this study. Most surgeons found that the 
increased dexterity allowed by the da Vinci® provided for 
easier suturing within the abdominopelvic cavity. 
Additionally, several analyses of these specific robotic 
procedures noted a decreased learning curve  for new 
surgeons, 5, 12, 43 as well as a tendency for operative time to 
decrease with surgeon experience.26 
CONCLUSION
Through this retrospective analysis it is clear that robotic 
surgery in urology bears many advantages. Whether 
through hybrid integration or full robotic procedures, 
there will be uses for robot-assisted surgery in the coming 
years. With that said, we must be careful not to take a 
broad view of the subject. There can be no general 
conclusion to the effectiveness of robot-assisted surgery 
as a whole, nor can there be a general conclusion to its 
effectiveness within urology, but rather each procedure 
must be evaluated individually. 
The original assessment tool used in this article 
specifically shows how the strengths of each technique 
benefit the field in a different way. By using this tool, 
practicality can be assessed for each procedure rather 
than grouping the techniques as a whole. Although the 
results show that there is a difference in the mean 
practicality score (Table 4), more examination is needed. 
Our exploratory research tool should be modified to 
allow for more distinct comparative evaluations of 
robotic and laparoscopic techniques. Even then, long-
term effects such as durability and oncologic outcomes 
must be assessed before a final conclusion is reached for 
each procedure. At this time we can only tentatively 
recommend the robotic techniques for each of the three 
procedures. For now, it is safe to conclude that minimally 
invasive robot-assisted surgery is a practical technique 
for all three urologic procedures, but must be further 
examined to determine if it is significantly more practical. 
LIMITATIONS
The original assessment tool has not yet undergone any 
formal tests for validity and reliability and is exploratory 
in nature. We hope to use this current study’s results to 
develop an assessment tool for further research, which 
would allow for more complete statistical analyses. 
Although we feel that this practicality assessment tool is 
in its infancy, we believe that the strength of this study 
lies in the large number of studies (91) that were 
incorporated through the review of the meta-analyses 
and comparative studies used to compile the data for our 
tables. 
FUTURE DIRECTIONS
The da Vinci®’s greatest strength is its versatility, a fact 
displayed by its use in many different medical specialties. 
Although well known for its utilization in urology and 
gynecology, the da Vinci® robot sparked tremendous 
advancements in other fields, such as cardiothoracic 
surgery. One of the crowning accomplishments of the da 
Vinci® system is that it allows the performing of coronary 
artery bypass grafting (CABG) surgery on a closed chest 
with a beating heart,45 a feat considered inconceivable 
only a few years ago. Further advancements for the future 
of robotic surgery include the utilization of remote 
telesurgery in which the surgeon and patient can be 
thousands of miles apart. Although current application 
of such technology is not yet mainstream, the first 
telesurgery procedure was performed in 2001, on a 
patient in France via a surgeon in New York.46 Possibly 
the most futuristic yet controversial technology is that of 
automated computer surgery.10 Such robots could provide 
the possibility of “error free” surgery and would further 
solidify a niche for robotic surgery. While such ideas 
seem futuristic, they are within reach given current 
technologies. The future of robotic surgery seems 
promising, with fields such as urology continuing to 
develop and improve the technology and techniques. 
While it is unlikely that robotic surgery will ever 
completely replace open surgery or even traditional 
laparoscopy, it is likely that the technique will see 
increased utilization as patients seek the most minimally 
invasive and technologically advanced methods. Overall, 
we have just scratched the surface of robotic surgery and 
in the future, these techniques should provide the chance 
for incredible innovation within the field of medicine. 
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Table 2: Quantitative Data Key
EBL
score 1 2 3 4 5
mL <150 151-200 201-250 251-300 >300
Operative
Duration
score 1 2 3 4 5
minutes <120 121-150 151-180 181-210 >210
Hospital Stay
score 1 2 3 4 5
days <1.0 1.1-1.6 1.6-2.1 2.1-2.6 >2.6
Cost
score 1 2 3 4 5
US $ <5,500 5,501-7000 7,001-8,500 8,501-10,000 >10,000
Table 3: Numerical Data Collection
Radical
Prostatectomy
Method Peri-operative
(EBL)
Operative
Duration
Hospital
Stay
Cost
Robotic Radical
Protatectomy
329.75 ml 22 207.5 mins 22 1.56 days 24 $6752 25
Laparoscopic 
Radical 
Prostatectomy
350.5 ml 22 224.75 mins 22 1.76 days 24 $5687 25
Pyeloplasty
Method Perioperative
(EBL)
Operative
Duration
Hospital
Stay
Cost
Robot-assisted 
Pyeloplasty
50 ml 31 194 min 31 1.54 days 33 $10,635 39
Laparoscopic
Pyeloplasty
158 ml 32 224 min 33 1.98 days 33 $10,311 39
Partial
Nephrectomy
Method Peri-operative
(EBL)
Operative
Duration
Hospital
Stay
Cost
RAPN 162 ml 36 191 min 36 2.6 days 39 $11,962 39
Laparoscopic
Nephrectomy
250 ml 41 210 min 41 3.2 days 39 $10,311 39
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Table 4: Scaled Scoring
Radical
Prostatectomy
Method Peri-operative
(EBL)
Operative
Duration
Hospital
Stay
Cost Mean
Practicality
Score
Robot-Assisted 5 4 2 2 3.25
Laparoscopic 5 5 3 2 3.75
Pyeloplasty
Method Peri-operative
(EBL)
Operative
Duration
Hospital
Stay
Cost Mean
Practicality
Score
Robot-assisted 1 4 2 5 3
Laparoscopic 2 5 3 4 3.5
Partial
Nephrectomy
Method Peri-operative
(EBL)
Operative
Duration
Hospital
Stay
Cost Mean
Practicality
Score
Robot-Assisted 2 4 5 4 3.75
Laparoscopic 3 4 5 5 4.25
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